4//SEC Filing
Cole Jeffrey Scott 4
Accession 0001213900-25-006635
CIK 0001937993other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 6:11 PM ET
Size
5.7 KB
Accession
0001213900-25-006635
Insider Transaction Report
Form 4
Cole Jeffrey Scott
Chief Operating Officer
Transactions
- Award
Stock Options
2025-01-23+25,000→ 25,000 totalExercise: $19.79From: 2026-02-01Exp: 2035-01-22→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Consists of options to purchase 25,000 shares of common stock, which shall vest 1/4 on February 1, 2026 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant.
Documents
Issuer
Cadrenal Therapeutics, Inc.
CIK 0001937993
Entity typeother
Related Parties
1- filerCIK 0001751100
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 6:11 PM ET
- Size
- 5.7 KB